Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment

David A Wheeler1, Naoko Takebe2, Toshinori Hinoue3

  • 1Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Cancer Cell
|November 20, 2020
PubMed

Insights

Molecular mechanisms behind exceptional cancer responses were uncovered in advanced disease patients. Analyzing tumor genetics and microenvironments revealed key pathways like DNA damage response and immune engagement.

Area of Science:

  • Oncology
  • Genomics
  • Cancer Biology

Background:

  • A small subset of advanced cancer patients exhibit prolonged survival despite similar clinical prognoses.
  • Understanding the molecular basis of these exceptional responses is crucial for advancing cancer therapy.

Purpose of the Study:

  • To investigate the genetic, epigenetic, and microenvironmental factors contributing to exceptional responses in cancer patients.
  • To identify actionable therapeutic targets and hypotheses for overcoming treatment resistance.

Main Methods:

  • Comprehensive genomic and epigenomic profiling of tumor biopsies from 111 exceptional responders.
  • Analysis of the tumor microenvironment using multiple high-throughput platforms.
  • Integrative analysis of multi-platform data to uncover response mechanisms.

Main Results:

  • Plausible therapeutic response mechanisms were identified in nearly 25% of exceptional responders.
  • Mechanisms were categorized into DNA damage response, intracellular signaling, immune engagement, and favorable genetic alterations.
  • Many tumors exhibited mechanisms across multiple categories, highlighting complex interactions.

Conclusions:

  • Integrative analysis of exceptional responders reveals diverse molecular mechanisms underlying prolonged survival.
  • Identified synthetic lethal relationships and rare genetic lesions offer potential therapeutic strategies.
  • The study provides a foundation for further research into oncogenic mechanisms and treatment response.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
52.6K